Clinical Trial Update: A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the antiviral activity of TMC310911 when co-administered with ritonavir in treatment-naive HIV-1 infection; the study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ritonavir (Ritonavir)
• TMC310911

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Human Immunodeficiency Virus Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2013-03-07